WENA (Anew Medical, Inc.) Sof foyda

Anew Medical, Inc. (WENA) olimlardan iborat ixcham shtat va tashqi pudratchilarga tayangan holda, laboratoriyalar tarmog'i orqali nevrologik dori vositalari uchun klinik sinovlar logistikasini optimallashtirmoqda. Joriy GURU.Markets platformasi grafigidagi kompaniyaning sof foydasi dinamikasi joriy tendentsiyalarni aks ettiradi, bunda 0.00 eng so'nggi metrika darajasini ifodalaydi. Emittentning o'sishi ALS va Altsgeymer kasalliklari uchun gen terapiyasi, shuningdek, Big Pharma bilan strategik sheriklikka asoslangan.

WENA - Anew Medical Sof foyda 25.06.2024 - 17.09.2024 oraligʻida

Anew Medical (WENA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi anewmeds.com|WENA - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Anew Medical, Inc.|WENA - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga xususiy kapital Anew Medical|WENA - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti anewmeds.com|WENA - Kompaniyaning yakuniy aktivlari
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Anew Medical, Inc.|WENA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Anew Medical Inc.|WENA - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Anew Medical, Inc.|WENA - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Anew Medical|Shoshilinch likvidlik koeffitsiyenti anewmeds.com
- foyda va bozor koeffitsiyentlari statistikasi:
WENA - Sof foyda
Kompaniyaning asosiy tahlili:WENA, anewmeds.com

Investorlar biznesning barqarorligini barcha operatsion va soliq xarajatlari chegirib tashlanganidan keyin qolgan daromad sifatida hisoblanadigan sof foyda tendentsiyalari orqali baholaydilar. ALS va Altsgeymer kasalliklari uchun gen terapiyasi yo'nalishida investitsiya kiritayotgan Anew Medical, Inc. (WENA) uchun ushbu ko'rsatkich R&D ishlanmalarini monetizatsiya qilish samaradorligini aks ettiradi, bu esa kompaniyaning marginal daromadi tahlilida yaqqol namoyon bo'lgan.

Toʻgʻridan-toʻgʻri raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Sof foyda|Sof foyda regencellbioscience.com|Kompaniyaning sof foydasi Axsome Therapeutics, Inc. (AXSM)|ACADIA Pharma - Kompaniya foydasi|Sof foyda XENE (Xenon Pharmaceuticals Inc)|Viking Therapeutics Corp (VKTX) - Kompaniyaning sof daromadi|SUPN: Sof daromad|catalystpharma.com (CPRX) - Sof daromad|DNLI (Denali Therapeutics Inc.) - Sof daromad|Harmony Biosciences Inc - Yakuniy foyda|Kompaniyaning sof foydasi Biohaven Pharmaceutical|Sof daromad Amylyx Corp (AMLX)|Sof foyda TRVI|PRAX - Kompaniyaning sof daromadi|Sof foyda AVXL (Anavex Life Sciences Corp.)|CBLL: Kompaniya foydasi|Prothena Biosciences - Sof foyda|Sof moliyaviy natija Alector, Inc. ALEC|ANNX: Sof foyda|Sof daromad Omeros|NGNE (Neurogene) - Sof foyda|Sof foyda AC Immune S.A.|Kompaniyaning sof foydasi Voyager Pharma (VYGR)|Kompaniyaning sof foydasi NMRA (Neumora Corp)|Scilex Holding Company - Sof daromad|Yakuniy foyda TVGN|Alpha Cognition Corp - Sof foyda|Sof moliyaviy natija cogrx.com CGTX|Inhibikase (IKT) - Kompaniyaning sof foydasi|Kompaniya foydasi SAVA|ASRT (Assertio Holdings) - Sof foyda|Sof daromad Coya (COYA)|Sof daromad VTGN (Vistagen Therapeutics)|Sof moliyaviy natija ovidrx.com|Acumen Pharma - Sof daromad|CRVO - Sof daromad|Alterity Therapeutics Ltd - Sof foyda|Kompaniyaning sof daromadi Clene Inc.|pepgen.com (PEPG) - Kompaniyaning sof foydasi|Kompaniya foydasi JUNS|RLMD (Relmada) - Sof foyda|Sof foyda Annovis Bio Corporation|Kompaniyaning sof foydasi Grace Therapeutics, Inc. (GRCE)|fireflyneuro.com - Kompaniya foydasi|Sof foyda KLTO (Klotho Neurosciences)|NeuroSense Therapeutics Ltd (NRSN) - Kompaniyaning sof daromadi|RVPH: Sof daromad|MTVA - Sof foyda|NeurAxis, Inc. (NRXS) - Kompaniyaning sof foydasi|Helius Medical Technologies - Yakuniy foyda|Kompaniyaning sof foydasi Passage Bio Inc.|Kompaniyaning sof daromadi Neuphoria NEUP|Sof foyda NERV|Sof foyda Athira Pharma Corp (ATHA)|Kompaniyaning sof foydasi Addex Therapeutics ADXN|ALZN: Kompaniya foydasi|Cyclerion - Sof foyda|Kompaniyaning sof daromadi Protagenic Therapeutics|KTTA (pasitheaclinics.com) - Sof daromad|Sof daromad Cortigent|Sof daromad ATXI|BCLI: Yakuniy foyda|Kompaniyaning sof foydasi Cara Therapeutics (CARA)|Sof daromad Chromocell Therapeutics Corp CHRO|Sof foyda ELYM (Eliem Therapeutics Inc.)|Intra-Cellular Therapies Inc. (ITCI) - Kompaniyaning sof daromadi|Longboard Pharmaceuticals - Sof foyda|MRNS (marinuspharma.com) - Kompaniya foydasi|NKGN: Sof foyda|NRBO - Sof moliyaviy natija|SAGE (Sage Therapeutics, Inc) - Sof foyda|Sof daromad Synaptogenix, Inc (SNPX)|Sof foyda TRVN|Sof foyda vigilneuro.com (VIGL)|Kompaniyaning sof foydasi Cerevel Therapeutics, Inc. CERE